المؤلفون: Quinn G; Department of Immunology, UT Southwestern Medical Center, Dallas, TX, USA., Maggiore G; Children's Research Institute, UT Southwestern Medical Center, Dallas, TX, USA., Li B; Department of Immunology, UT Southwestern Medical Center, Dallas, TX, USA. lib3@chop.edu.; Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA. lib3@chop.edu.; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. lib3@chop.edu.; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA. lib3@chop.edu.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, USA. lib3@chop.edu.

المصدر: BMC cancer [BMC Cancer] 2024 Sep 18; Vol. 24 (1), pp. 1157. Date of Electronic Publication: 2024 Sep 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Immunity, Innate*/genetics , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Neoplasms*/immunology , Neoplasms*/genetics , Neoplasms*/pathology , Signal Transduction* , Genomics*/methods, Humans ; Gene Expression Regulation, Neoplastic

المؤلفون: Wen J; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, 430030, China., Liu D; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhu H; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, 430030, China. zhuhongtao@tjh.tjmu.edu.cn., Shu K; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, 430030, China. kshu@tjh.tjmu.edu.cn.

المصدر: Journal of neuroinflammation [J Neuroinflammation] 2024 Sep 16; Vol. 21 (1), pp. 226. Date of Electronic Publication: 2024 Sep 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101222974 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-2094 (Electronic) Linking ISSN: 17422094 NLM ISO Abbreviation: J Neuroinflammation Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/physiology , Tumor Microenvironment*/immunology , Glioma*/pathology , Glioma*/therapy , Glioma*/immunology , Neutrophils*/pathology , Neutrophils*/immunology , Brain Neoplasms*/pathology , Brain Neoplasms*/therapy , Brain Neoplasms*/immunology, Humans ; Animals

المؤلفون: Xu J; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277 West Yanta Road., Xi'an, 710061, Shaanxi, People's Republic of China., Yu B; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277 West Yanta Road., Xi'an, 710061, Shaanxi, People's Republic of China., Wang F; Phase I Clinical Trial Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China. wangfan230@outlook.com., Yang J; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277 West Yanta Road., Xi'an, 710061, Shaanxi, People's Republic of China. yangjin@xjtu.edu.cn.; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277 West Yanta Road., Xi'an, 710061, Shaanxi, People's Republic of China. yangjin@xjtu.edu.cn.; Phase I Clinical Trial Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China. yangjin@xjtu.edu.cn.; Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China. yangjin@xjtu.edu.cn.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Sep 13; Vol. 73 (11), pp. 233. Date of Electronic Publication: 2024 Sep 13.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/genetics , Stomach Neoplasms*/pathology , Single-Cell Analysis*/methods , Precision Medicine*/methods , Tumor Microenvironment*/genetics , Tumor Microenvironment*/immunology , Sequence Analysis, RNA*/methods, Humans ; Genetic Heterogeneity ; Carcinogenesis/genetics ; Animals

المؤلفون: Xu S; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China. xushengshan@jmszxyy.com.cn., Chen X; Department of Medical Oncology, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China., Ying H; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Chen J; Department of Oncology, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Ye M; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Lin Z; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Zhang X; Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Shen T; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Li Z; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Zheng Y; Department of Radiology, Jiangmen Wuyi Hospital of Traditional Chinese Medicine, Jiangmen, Guangdong, China., Zhang D; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Ke Y; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Chen Z; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China., Lu Z; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China. lzm219@jnu.edu.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Sep 12; Vol. 24 (1), pp. 1138. Date of Electronic Publication: 2024 Sep 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma of Lung*/genetics , Adenocarcinoma of Lung*/pathology , Adenocarcinoma of Lung*/mortality , Adenocarcinoma of Lung*/immunology , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Tumor Microenvironment*/genetics , Tumor Microenvironment*/immunology, Humans ; Prognosis ; Biomarkers, Tumor/genetics ; Immunotherapy ; Gene Expression Regulation, Neoplastic ; Gene Expression Profiling ; Female ; Single-Cell Analysis/methods ; Male ; Transcriptome ; Machine Learning ; Multiomics

المؤلفون: Berzaghi R; Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway., Gundersen K; Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway., Dille Pedersen B; Department of Radiation Oncology, University Hospital of North Norway, Tromsø, Norway., Utne A; Department of Radiation Oncology, University Hospital of North Norway, Tromsø, Norway., Yang N; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway., Hellevik T; Department of Radiation Oncology, University Hospital of North Norway, Tromsø, Norway., Martinez-Zubiaurre I; Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.

المصدر: Frontiers in immunology [Front Immunol] 2024 Sep 06; Vol. 15, pp. 1433237. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Cancer-Associated Fibroblasts*/immunology , Cancer-Associated Fibroblasts*/metabolism , Cancer-Associated Fibroblasts*/radiation effects , Tumor Microenvironment*/immunology , Tumor Microenvironment*/radiation effects , Lung Neoplasms*/immunology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Cytokines*/metabolism , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology, Humans ; Cellular Senescence/radiation effects ; Cellular Senescence/immunology

المؤلفون: Liu Q; Huaian Hospital of Huaian City, Huaian, China., Niu R; Huaian Hospital of Huaian City, Huaian, China., Ye Y; Jiangsu University, Zhenjiang, China., Li J; Huaian Hospital of Huaian City, Huaian, China.

المصدر: The journal of gene medicine [J Gene Med] 2024 Sep; Vol. 26 (9), pp. e3723.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9815764 Publication Model: Print Cited Medium: Internet ISSN: 1521-2254 (Electronic) Linking ISSN: 1099498X NLM ISO Abbreviation: J Gene Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/immunology , Carcinoma, Hepatocellular*/genetics , Carcinoma, Hepatocellular*/chemically induced , Carcinoma, Hepatocellular*/pathology , Benzhydryl Compounds*/adverse effects , Liver Neoplasms*/immunology , Liver Neoplasms*/genetics , Liver Neoplasms*/chemically induced , Liver Neoplasms*/pathology , Tumor Microenvironment*/immunology , Tumor Microenvironment*/drug effects , Phenols*/adverse effects , Phenols*/toxicity , Gene Expression Regulation, Neoplastic*/drug effects , Disease Progression*, Humans ; Cell Line, Tumor ; Gene Expression Profiling ; Biomarkers, Tumor/genetics

المؤلفون: Hu X; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China., Wu Y; Department of Integrated Traditional Chinese and Western Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China., Wang L; Department of Integrated Traditional Chinese and Western Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China., Yang F; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China., Ye L; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China., Chen X; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China., Song X; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China., Wei P; Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary, Hospital, School of Medicine, Tongji University, Shanghai, China.

المصدر: The journal of gene medicine [J Gene Med] 2024 Sep; Vol. 26 (9), pp. e3736.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9815764 Publication Model: Print Cited Medium: Internet ISSN: 1521-2254 (Electronic) Linking ISSN: 1099498X NLM ISO Abbreviation: J Gene Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/pathology , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/therapy , Lung Neoplasms*/immunology , Lung Neoplasms*/pathology , Immunotherapy*/methods , Single-Cell Analysis*/methods , Biomarkers, Tumor*/genetics, Humans ; Sequence Analysis, RNA/methods ; Gene Expression Regulation, Neoplastic ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Gene Expression Profiling

المؤلفون: Kalinina AA; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 24, Kashirskoe sh, Moscow, 115478, Russia. aakalinina89@gmail.com., Tilova LR; Kabardino-Balkarian State University named after H.M. Berbekov, 173, Chernyshevsky st, Nalchik, 360004, Russia., Kazansky DB; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 24, Kashirskoe sh, Moscow, 115478, Russia., Khromykh LM; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 24, Kashirskoe sh, Moscow, 115478, Russia.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Sep; Vol. 94 (3), pp. 407-420. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Cyclophilin A* , Tumor Microenvironment*/drug effects , Tumor Microenvironment*/immunology , Melanoma, Experimental*/drug therapy , Melanoma, Experimental*/immunology , Melanoma, Experimental*/pathology , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Mice, Inbred C57BL* , Lymphoma*/drug therapy , Lymphoma*/pathology , Lymphoma*/immunology, Animals ; Mice ; Humans ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/pharmacology ; Cell Line, Tumor ; Female ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/pharmacology

المؤلفون: Dai Z; Department of Radiation Oncology, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China., Lin B; Department of Radiation Oncology, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China., Cao Y; Department of Oncology, Dongguan Songshan Lake Tungwah Hospital, Dongguan, China., Wang L; Department of Radiation Oncology, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China., Liao K; Department of Radiation Oncology, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China., Guo L; Department of Oncology and Hematology, The Sixth People's Hospital of Huizhou City, Huiyang Hospital Affiliated to Southern Medical University, Huizhou, China. Electronic address: 13802869551@139.com., Zhang J; Department of Radiation Oncology, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China. Electronic address: zhangjian@gzhmu.edu.cn.

المصدر: Computers in biology and medicine [Comput Biol Med] 2024 Sep; Vol. 180, pp. 108937. Date of Electronic Publication: 2024 Jul 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 1250250 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0534 (Electronic) Linking ISSN: 00104825 NLM ISO Abbreviation: Comput Biol Med Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/immunology , COVID-19*/genetics , Melatonin*/therapeutic use , Adenocarcinoma of Lung*/drug therapy , Adenocarcinoma of Lung*/genetics , Adenocarcinoma of Lung*/immunology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/immunology , Tumor Microenvironment*/immunology , Tumor Microenvironment*/drug effects , SARS-CoV-2*/immunology , Drug Resistance, Neoplasm*/genetics , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/pharmacology, Humans ; ErbB Receptors/genetics ; Animals ; Mice ; Gene Expression Regulation, Neoplastic/drug effects ; Transcriptome ; Female ; Male ; Circadian Rhythm/genetics

المؤلفون: O'Connell BC; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA brendaoconnell5@gmail.com., Hubbard C; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA., Zizlsperger N; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA., Fitzgerald D; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA., Kutok JL; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA., Varner J; University of California San Diego, La Jolla, California, USA., Ilaria R Jr; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA., Cobleigh MA; Rush University Medical Center, Chicago, Illinois, USA., Juric D; Massachusetts General Hospital, Boston, Massachusetts, USA., Tkaczuk KHR; University of Maryland School of Medicine, Baltimore, Maryland, USA., Elias A; University of Colorado School of Medicine, Aurora, Colorado, USA., Lee A; UT Health East Texas, Tyler, Texas, USA., Dakhil S; Cancer Center of Kansas, Wichita, Kansas, USA., Hamilton E; Sarah Cannon Research Institute, Nashville, Tennessee, USA., Soliman H; Moffitt Cancer Center, Tampa, Florida, USA., Peluso S; Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Aug 30; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 30.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors*/pharmacology , Immune Checkpoint Inhibitors*/therapeutic use , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/immunology , Tumor Microenvironment*/drug effects , Tumor Microenvironment*/immunology, Female ; Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Extracellular Matrix/drug effects ; Extracellular Matrix/metabolism ; Neoplasm Metastasis ; Tumor-Associated Macrophages/metabolism ; Tumor-Associated Macrophages/immunology ; Tumor-Associated Macrophages/drug effects ; Clinical Trials, Phase I as Topic